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Abstract This study aims to explore the gastrointestinal
dysfunction and the changes of dopaminergic, nitric
oxidergic, and cholinergic neurons in the myenteric plexus
of a Parkinson’s disease (PD) rat model. A PD rat model
was induced through unilateral substantia nigra administra-
tion of 6-hydroxydopamine. Four weeks later, the feces in
1 h and residual solid food in stomach at 2 h after feeding
were measured. Changes in tyrosine hydroxylase (TH) in
substantial nigra, TH, choline acetyltransferase (ChAT), and
neuronal nitric oxide synthase (nNOS) in gastric antrum
and colon tissue were examined by immunohistochemistry.
Reverse transcription (RT) polymerase chain reaction
(PCR) and Western blot were used to evaluate and compare
the levels of messenger RNA (mRNA) and protein
expression of TH, ChAT, and nNOS in the GI tract between
normal and 6-hydroxydopamine-lesioned rats. Compared
with control samples, the number of TH
+ cells in the
damaged side of substantia nigra of 6-hydroxydopamine-
lesioned rats decreased significantly (P<0.01). The weight
and water content of the fecal matter decreased (P<0.01),
and the percentage of residual solid food increased
(P<0.01). The average integrated optical densities of TH-
positive areas in the gastric antrum and colon tissue
increased significantly (P<0.01), nNOS decreased signifi-
cantly (P<0.01), and there were no significant changes in
ChAT (P>0.05). TH and nNOS mRNA levels in the
gastric antrum and proximal colon decreased (P<0.01),
there were no significant changes in ChAT mRNA levels
(P>0.05). The protein levels of TH in the GI tract were
significantly increased (P<0.01), nNOS significantly
decreased (P<0.01), and ChAT had no significant changes
(P>0.05). 6-Hydroxydopamine-lesioned rats had delayed
gastric emptying and constipation that might be related to
the gastrointestinal TH increase and nNOS decrease.
These symptoms were not related to changes in cholinergic
transmitters.
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Introduction
Parkinson’s disease (PD) is a disorder with an elusive
cause that affects multiple systems. The disease selec-
tively affects neurons from the central nervous system to
the peripheral nervous system (Bonifati et al. 2004;
Hirsch 1999; Schapira 1998;S h e r e re ta l .2002)a n di s
frequently accompanied by various gastrointestinal symp-
toms. Studies have shown that the gastrointestinal
symptoms of PD mainly include dysphagia, delayed
gastric emptying, and constipation (Edwards et al. 1991;
Cersosimo and Benarroch 2008; Natale et al. 2008;
Pfeiffer 1998;P o e w e2008). Gastrointestinal symptoms
(especially constipation) can occur several years earlier
than the typical PD motor symptoms (Abbott et al. 2001).
PD is a multicentric neurodegenerative disorder that
affects several neuronal structures in addition to the
substantia nigra, including the enteric nervous system
(ENS; Braak and Del Tredici 2008, 2009). Damage to the
ENS can occur during the early stage of PD, and it can
happen even before the central nervous system is affected
(Braak et al. 2006). In Parkinson’s patients, Lewy bodies
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plexus and submucosal plexus (Braak et al. 2006;
Lebouvier et al. 2008; Wakabayashi et al. 1988). These
positive inclusion bodies have been found in patients
with advanced Parkinson’s disease and in asymptomatic
patients with PD-related lower brainstem lesions (Braak
et al. 2006). Therefore, these findings support the
hypothesis that gastrointestinal tract is an early target of
PD (Hawkes et al. 2007). Currently, it is not clear
whether PD leads to the loss of enteric neurons. Various
studies have shown that most PD patients have dopami-
nergic neuronal loss in the colonic myenteric plexus and
submucosal plexus, whereas other types of neurons are
not affected (Singaram et al. 1995). No obvious neuronal
loss in the submucosal plexus has been found in colon
biopsies from patients with PD (Lebouvier et al. 2008).
Systemic administration of the selective dopaminergic neuron
toxin 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)
leads to the loss of dopaminergic neurons in the intestinal
tracts of mice (Anderson et al. 2007), but MPTP-treated
monkeys have an increased number of neurons in their
ganglia (Chaumette et al. 2009). MPTP causes a transient
increase of stool frequency and colon relaxation lesions in
mice (Anderson et al. 2007), but this effect is inconsistent
with the slow gastrointestinal motility of clinical PD
patients. Therefore, although inhibitory intestinal dopami-
nergic neurons could be impaired in PD, these neurons are
not the only neuropathological target of the disease. In
addition, intestinal non-dopaminergic neurons could also
be impaired in the disease. Neurotransmitters related to
PD gastrointestinal dysfunction could be involved in the
intestinal dopaminergic, cholinergic, and nitric oxidergic
systems.
A PD mouse model was induced by intraperitoneal
injection of MPTP, and there was no change in nitric
oxidergic neurons (Anderson et al. 2007). Another study
showed that PD rat model induced by directional stereo-
taxic brain injection of neurotoxin 6-OHDA had slow colon
motility accompanied with nitric oxidergic neuron loss in
the myenteric plexus (Blandini et al. 2008). Other studies
showed that a primate PD model induced by MPTP led to
an increase in nitric oxidergic neurons (Chaumette et al.
2009). Most studies have shown that gastrointestinal
cholinergic transmitters did not change in PD (Anderson
et al. 2007; Chaumette et al. 2009;G r e e n ee ta l .2009). In
order to investigate the relationship between PD gastro-
intestinal dysfunction and the alteration of gastrointesti-
nal neurotransmitters, 6-OHDA was microinjected into
one side of the nigrostriatal system of the brain to
generate a PD animal model through the impairment of
rat dopaminergic neurons, and the effect of the alterations
of the neurotransmitters in the ENS on gastrointestinal
function was observed.
Materials and Methods
Materials, Reagents, and Instruments
Female Sprague–Dawley (SD) rats with a body weight of
180–220 g were provided by the Laboratory Animal
Research Center at Zhengzhou University. 6-OHDA and
apomorphine (APO) were purchased from Sigma-Aldrich,
Co. (USA). A rabbit anti-TH monoclonal antibody was
purchased from Cell Signaling Technology, Inc. (USA). A
rabbit anti-β-actin polyclonal antibody was purchased from
Sigma-Aldrich, Co. (USA). A rabbit anti-rat nitric oxide
synthase I polyclonal antibody and a rabbit anti-ChAT
polyclonalantibodywerepurchasedfromBeijingBiosynthesis
Biotechnology Co., Ltd. The immunohistochemistry SP kit
and the diaminobenzidine (DAB) staining kit were purchased
from Beijing Zhongshan Golden Bridge Biotechnology Co.,
Ltd. The reverse transcription and PCR kits were purchased
from Beijing TransGen Biotech Co., Ltd. The PCR primers
were synthesized by Beijing SBS Genetech Co., Ltd. The
stereotaxic instrument was Jiangwan type I from Shanghai.
The PCR GeneAmp System (2700) came from Applied
Biosystems (USA).The electrophoresis apparatus (DYY-6C)
was from the Beijing Liuyi Instrument Factory.
Generation of the Rat PD Model
Eighty female SD rats were randomly divided into 6-OHDA
group (P group) and control group (C group) with 40 rats in
each group. The rats were anesthetized with intraperitoneal
injectionof10%chloralhydrate(400mg/kg)toeliminatepain
and suffering and fixed on the stereotaxic instrument. The
upper incisor bar was 2.4 mm lower than the ear bar so that
anterior and posterior fontanels were on the same plane. The
scalp was sheared, and routine disinfection was performed.
The scalp was cut open along the longitudinal midline.
Referring to “The Brain Stereotaxic Atlas of the Rat” by
Xinmin Bao, we set anterior fontanel as the origin in order to
determine the coordinates of the right substantia nigra. The
first point was 5.0 mm behindthe anterior fontanel, 2.4 mm to
the right of the midline, and 7.6 mm below dura mater. The
secondpointwas5.6mmbehindtheanteriorfontanel,1.6mm
to the right of the midline, and 7.8 mm below dura mater. The
skull was drilled, and 3 μlo f6 - O H D A[ 4μg/ul, dissolved in
saline containing 0.02% (w/v) of vitamin C] was slowly
injected into each coordinate point with a microsyringe at a
speed of 1 μl/min. After the injection, the needle was kept in
place for 10 min, and then it was slowly withdrawn at a
speed of 1 mm/min. Then disinfection was performed, and
the skin was sutured. The rats were allowed to feed and drink
freely after they woke up. For the control group, 3 μlo f
saline containing 0.02% vitamin C was injected into each
coordinate point in the same manner.
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intraperitoneally injected to induce the rats to perform
leftwards rotations (uninjured side). The number of rota-
tions the animals perform within a half hour was recorded,
and the animals that performed over 210 rotations/30 min
(seven turns/min) were selected as successful PD models.
Experimental Methods
Measurement of Colon Motility by 1-h Stool Collection Each
animal was individually kept in a clean cage with filter
paper covering the bottom for 1 h. Stools were collected
immediately after expulsion and placed in sealed tube. The
total stools were weighed to provide a wet weight, then
dried at 65°C for 12 h and weighed again to provide a dry
weight. Stool water content was calculated as follows:
Stool water content % ðÞ
¼ Wet weight   Dry weight ðÞ =Wet weight   100%
Determination of Residual Solid Food in the Stomach Follow-
ing a 12-h fasting, mice were allowed free access to food
for 1 h. Two hours later, animals were killed, and the
stomach contents were weighed. The stomach was re-
moved, dried with filter paper, and weighed (total weight).
The stomach was cut open along the greater curvature of
the stomach, and its contents were washed out. Then, the
stomach was dried with filter paper and weighed again (net
weight). Food was weighed before and after the feeding
period to determine the amount consumed. Gastric residual
food percentage was calculated as follows:
Gastric residual food percentage % ðÞ
¼ Total weight   Net weight ðÞ =Food consumed   100%
Immunohistochemistry On the fourth week, the substantia
nigra and gastrointestinal tracts of 10 rats from each group
were examined by immunohistochemistry. The tissues were
fixed with 4% paraformaldehyde, embedded in paraffin and
cut into 5-μm sections. After dewaxing and dehydration,
the sections were incubated in 3% H2O2 at room temper-
ature for 15 min, boiled in a microwave to retrieve the
antigen, and then blocked with 10% goat serum for 10 min.
The serum was removed, and primary antibody was added
(rabbit anti-rat TH monoclonal antibody, rabbit anti-rat
nitric oxide synthase I polyclonal antibody, and rabbit anti-
rat ChAT polyclonal antibody). After incubating the tissue
overnight at 4°C, the sections were washed with Tris-
buffered saline (TBS) three times for 5 min each time, and
then incubated with a secondary antibody at 37°C for
30 min. The sections were washed with TBS three times
(5 min each time) and stained with DAB. Then, sections
were observed under a microscope to stop the staining
accordingly. After staining with hematoxylin, the sections
were dehydrated, cleared, and mounted with mounting
medium. Ten slides were randomly taken with the
corresponding sections from each rat group, and 10 fields
were randomly chosen under high magnification. TH-
positive neurons in the substantia nigra were counted, and
the average number was determined. Using Biosens Digital
Imaging System v1.6 analysis software, the average
integrated optical density was calculated in TH-, nNOS-
and ChAT-immunoreactive regions of the gastric antrum
and colon.
Western Blot for TH, nNOS, and ChAT Samples of the
gastric antrum and proximal colon were harvested from the
rats. All samples were washed with phosphate-buffered
saline and homogenized in 300 μl cold lysis buffer (1%
Nonidet P-40, 10 mM Tris–HCl, pH 8.0, 150 mM NaCl,
0.1% sodium dodecyl sulfate, 1 mM EDTA, 5 μg/ml
leupeptin, 5 μg/ml aprotinin, 1 mM PMSF, 0.5% deoxy-
cholic acid, and 1 mM sodium orthovanadate, all purchased
from Sigma Company). After electrophoresis and transfer-
ring of proteins onto the nitrocellulose membrane (NC
membrane, Millipore, Billerica, MA, USA), the membrane
was blocked in TBS with Tween 20 (TTBS) with 5%
nonfat milk and incubated with primary antibodies for TH,
nNOS, ChAT, or β-actin overnight at 4°C, followed by
incubation in the appropriate secondary antibodies for 1 h
at room temperature. The blots were washed extensively in
TTBS after incubation with primary and secondary anti-
bodies, scanned with Odyssey Infrared Imager (LI-COR,
Lincoln, NE, USA), and analyzed by Odyssey software
(version 1.2).
Reverse Transcription Polymerase Chain Reaction Total
RNA was isolated from tissue using the conventional
Trizol method. First strand complementary DNA (cDNA)
was synthesized with a reverse transcription kit. Based
on GenBank sequences, specific primers for PCR
amplification of the target genes were designed by
Primer3 primer design software. The TH upstream primer
sequence was 5′-GACGGCGACAGAGTCTCAT-3′, and the
downstream primer sequence was 5′-AGGCTGGTAGGTTT
GATCTTG-3′. The nNOS upstream primer sequence was
5′-CACATTTGCATGGGCTCG-3′, and the downstream
primer sequence was 5′-GACCTGAGATTCCCTTTGTT-3′.
The ChAT upstream primer sequence was 5′-CCATTT
GATGGCATCGTC-3′, and the downstream primer sequence
was 5′-CTGGTAAAGCCTGTAGTAAGC-3′.T h eβ-actin1
upstream primer sequence was 5′-CACCCGCGAGTA
CAACCTTC-3′, and the downstream primer sequence was
5′-CCCATACCACCATCACACC-3′.T h eβ-actin2 upstream
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and the downstream primer sequence was 5′-AGGGGCCA
TCCACAGTCTTC-3′. The PCR reaction conditions were
94°C predenaturation for 2 min; 94°C denaturation for 30 s,
55°C annealing for 30 s (55°C for TH, 50°C for nNOS, and
52°C for ChAT), and 72°C extension for 2 min. These steps
were repeated for 30 cycles, and afterwards, there was a 72°C
extension period for 6 min. PCR product bands were
examined on a 2% electrophoretic agarose gel. The average
densities of the target gene bands and the internal control
bands from both the control group and the 6-OHDA group
were analyzed and compared using a D-140 imaging analysis
system.
All the experiments are approved by the appropriate
animal experimentation committee.
Statistical Methods
The results of the statistical analyses are shown as mean±
standard deviation (x±s). The analyses were conducted with
SPSS 16.0 software. The means of the different groups
were compared using t test, and a value of p<0.05 was
considered statistically significant.
Results
Substantia Nigra TH Immunohistochemistry
TH-positive cells are dopaminergic neurons, and the cyto-
plasm of these cells has a brown color. After HE staining, the
nuclei of these cells also had a dark blue color. The number of
TH-positive cells in the damaged side of the substantia nigra
was markedly lower for the 6-OHDA group (9.00±2.94/HP)
thanfor the control group (38.8±5.47/HP),and thisdifference
was significant (P<0.01; Fig. 1).
One-Hour Fecal Output
The fecal outputs of the 6-OHDA group of rats (fecal
wet weight, 1.047±0.124 g and fecal dry weight, 0.812±
0.093 g) were significantly less than the output of the
control group (fecal wet weight, 2.329±0.287 g and fecal
Table 1 Fecal wet weight, dry weight, water content, and residual solid food percentage in the 6-OHDA and control groups (x±s, n=10)
Group Fecal wet weight (g) Fecal dry weight (g) Water content (%) Stomach residual percentage (%)
Control 2.329±0.287 1.384±0.232 40.464±2.675 42.297±2.581
6-OHDA 1.047±0.124
* 0.812±0.093
* 22.442±1.180
* 72.316±3.834
*
*P<0.01 compared to the control group
Fig. 1 TH immunohistochemi-
cal staining of the rat substantia
nigra. a, c Control group; b,
d 6-OHDA group. On the fourth
week, the substantia nigra of 10
rats from each group were
examined by immunohisto-
chemistry. TH-positive cells are
dopaminergic neurons, and the
cytoplasm of these cells has a
brown color. After HE staining,
the nuclei of these cells also had
a dark blue color. The number
of TH-positive cells in the dam-
aged side of the substantia nigra
was markedly lower for the 6-
OHDA group (9.00±2.94/HP)
than for the control group
(38.8±5.47/HP), and this
difference was
significant(P<0.01)(n=10)
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of the 6-OHDA group of rats (22.44±1.18%) was
significantly lower than that of control group (40.46±
2.68%; P<0.01), which indicates that the colon motility of
the 6-hydroxydopamine lesion’s rats was significantly
slower (Table 1).
The Changes of Stomach Solid Food Emptying Capability
Compared with control group, the percentage of residual
solid food in the stomach of 6-OHDA group rats (72.32±
3.83%) was significantly higher than that of control group
(42.30±2.58 %; P<0.01), indicating that stomach emptying
of 6-OHDA group rats is delayed (Table 1).
Immunohistochemical Staining of the Gastrointestinal
Myenteric Plexus
Immunohistochemical Analysis of TH Ab r o w nc o l o r
indicated TH-positive neurons. The average integrated
optical density of the TH-positive areas of the gastric
antrum and the proximal colon myenteric plexus for the
6-OHDA group were 147.74±13.92 and 150.45±10.09,
respectively. These values were significantly higher than
those of the control group (95.32±11.72 and 98.20±4.84,
respectively), and the difference was statistically significant
(P<0.01; Fig. 2).
Immunohistochemical Analysis of nNOS A brown color
indicated nNOS-positive cells (which were primarily
nNOS-positive neurons and nerve fibers). The average
integrated optical densities of the nNOS-positive areas of
the gastric antrum and the proximal colon myenteric plexus
of the PD group were 87.56±7.50 and 104.11±5.22,
respectively. These values were significantly lower than
those of the control group (132.02±11.91, 142.82±6.32),
and the difference between the two groups was statistically
significant (P<0.01; Fig. 3).
Immunohistochemical Analysis of ChAT The average
integrated optical densities of the ChAT-positive areas
of the gastric antrum and the proximal colon myenteric
plexus in the PD group were 109.36±3.37 and 104.73±
5.93, respectively. These values were not significantly
different from those of the control group (112.02±4.94,
104.83±4.35; P>0.05; Fig. 4).
Fig. 2 Immunohistochemistry of TH expression in the myenteric
plexus. a, c The gastric antrum and colon tissue of the control group,
respectively. b, d The gastric antrum and colon tissue of the 6-OHDA
group, respectively. The magnification is ×400. On the fourth week,
the gastrointestinal tracts of 10 rats from each group were examined
by immunohistochemistry. We calculated the average integrated
optical density in TH-immunoreactive regions of the gastric antrum
andthecolon.AbrowncolorindicatedTH-positiveneurons.Theaverage
integrated optical density of the TH-positive areas of the gastric antrum
and the proximal colon myenteric plexus for the 6-OHDA group were
147.74±13.92 and 150.45±10.09, respectively. These values were
significantly higher than those of the control group (95.32±11.72
and 98.20±4.84, respectively), and the difference was statistically
significance (P<0.01; n=10)
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Antrum and Colon Smooth Muscle
The protein extracts from the gastric antrum and proximal
colon were from two groups of rats (n=10). The results of
Western blot (Fig. 5) indicated that the protein levels of TH
were significantly increased in the GI tract of the 6-OHDA
lesion’sr a t s( P<0.01); additionally, nNOS decreased signif-
icantly (P<0.01), and there were no significant changes in
ChAT (P>0.05), which were consistent with the results of
immunohistochemistry. The quantitative analysis using β-
actin as an internal reference showed a significant increase of
TH, from 0.33±0.02 to 2.53±0.17 (P<0.01) in the stomach
and from 0.20±0.02 to 0.48±0.04 (P<0.01) in the colon.
The protein levels of nNOS in the gastric antrum and
proximal colon tissue in 6-OHDA group were decreased
significantly, from 4.56±0.52 to 3.21±0.34 (P<0.01) in the
stomach and from 4.25±0.46 to 1.36±0.12 (P<0.01) in the
colon. There were no significant changes in the protein levels
of ChAT between control group and 6-OHDA group, from
0.14±0.01 to 0.13±0.02(P>0.05) in the stomach and from
0.55±0.07 to 0.53±0.06(P>0.05) in the colon (Fig. 5).
mRNA Levels of TH, nNOS, and ChAT in the Gastric
Antrum and Colon Smooth Muscle
Using the RT-PCR method, the TH product size was 1,184 bp,
the β-actin2 product size was 595 bp, the nNOS product size
was 386 bp, the β-actin1 product size was 207 bp, and the
ChAT product size was 315 bp. TH messenger RNA (mRNA)
levels of the gastric antrum and in the proximal colon tissue in
6-OHDA group were 0.662±0.011and 0.585±0.012. These
values were significantly lower than those of the control group
(1.232±0.027, 1.172±0.026), and the difference between the
two groups was statistically significant (P<0.01). nNOS
mRNA levels of the gastric antrum and in the proximal colon
tissue in 6-OHDA group were 0.746±0.012 and 0.716±
0.015, respectively. These values were significantly lower
than those of the control group (1.563±0.031, 1.489±0.030),
and the difference between the two groups was statistically
significant (P<0.01). ChAT mRNA levels of the gastric
antrum and in the proximal colon tissue in 6-OHDA group
were 1.157±0.037 and 1.154±0.031. These values were not
significantly different from those of the control group (1.134±
0.067, 1.138±0.069; P>0.05; Fig. 6,T a b l e2).
Fig. 3 Immunohistochemistry of nNOS expression in the myenteric
plexus. a, c The gastric antrum and colon tissue of the control group,
respectively. b, d The gastric antrum and colon tissue of the 6-OHDA
group, respectively. The magnification is ×400. On the fourth week,
the gastrointestinal tracts of 10 rats from each group were examined
by immunohistochemistry. We calculated the average integrated
optical density in nNOS-immunoreactive regions of the gastric antrum
and the colon. A brown color indicated nNOS-positive cells (which
were primarily nNOS-positive neurons and nerve fibers). The average
integrated optical densities of the nNOS-positive areas of the gastric
antrum and the proximal colon myenteric plexus of the 6-OHDA
group were 87.56±7.50 and 104.11±5.22. These values were
significantly lower than those of the control group (132.02±11.91,
142.82±6.32), and the difference between the two groups was
statistically significant (P<0.01; n=10)
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Dopamine (DA) has recently been considered as an enteric
neurotransmitter, since DA, TH, and DAT coexist in enteric
neurons(Lietal.2004). Gastrointestinal dopaminergic system
can generate a large amount of DA. Dopamine inhibits gut
motility and protects gastroduodenal mucosa against ulcer
formation (Haskel and Hanani 1994; Glavin and Hall 1995).
Impaired gastric emptying (gastroparesis) and prolonged
GET1/2 (the average time to empty half of the gastric
contents) in PD patients could be induced or enhanced by
increasing gastric DA concentration (Hardoff et al. 2001).
After levodopa treatment, PD patients with a smooth response
had an even longer mean GET1/2. However, some PD
patients had a lower level of DA in the muscularis externa of
the colon (Singaram et al. 1995). Another group failed to find
overt neuronal loss in the colon submucosal plexus in colonic
biopsies taken from a few patients (Lebouvier et al. 2008).
Systemic administration of the selective dopaminergic neu-
rotoxin MPTP causes a loss of enteric dopamine neurons in
mice and non-human primates (Anderson et al. 2007;
C h a u m e t t ee ta l .2009) and, interestingly, has been associated
with an increased number of neurons per ganglia in the
MPTP-treated monkey(Chaumette et al. 2009).
The delay of stomach emptying in PD patients is mainly
expressed as bloating, early satiety, nausea, etc. Edwards et
al. (1991) surveyed PD patients and found 24% of reported
nausea and 45% of reported bloating. Greene et al. (2009)
further confirmed that rotenone-induced PD rats had an
obvious delay in stomach emptying. Our study showed that
stomach emptying slowed down remarkably in the 6-
OHDA group rats and that the percentage of residual food
in their stomach after 2 h was significantly higher than that
in the control group. The ENS can control the movement of
the gastrointestinal tract independently. DA can lead to the
relaxation of smooth muscle and inhibit stomach motility
(Schuurkes and Van Nueten 1981). An increase in DA
concentration in the stomach can induce or aggravate the
gastroparesis of PD patients and extend the gastric half-
emptying time (Hardoff et al. 2001).The dopamine D2
receptor blocker domperidone can improve the gastro-
paresis in PD patients (Soykan et al. 1997; Tonini et al.
2004). Anderson et al. (2007) generated a PD mouse model
through intraperitoneal injection of the neurotoxin MPTP,
which caused a 40% loss of dopaminergic neurons in the
intestinal tract. Chaumette et al. studied gastrointestinal
neurotransmitters in an MPTP-induced PD animal model
and found that there was gastrointestinal dopaminergic
Fig. 4 Immunohistochemistry of ChAT expression in the myenteric
plexus. a, c The gastric antrum and colon tissue of the control group,
respectively. b, d The gastric antrum and colon tissue of the 6-OHDA
group, respectively. The magnification is ×400. On the fourth week,
the gastrointestinal tracts of 10 rats from each group were examined
by immunohistochemistry. We calculated the average integrated
optical density in ChAT-immunoreactive regions of the gastric antrum
and the colon. A brown color indicated ChAT-positive neurons.
The average integrated optical densities of the ChAT-positive areas
of the gastric antrum and the proximal colon myenteric plexus in
the 6-OHDA group were 109.36±3.37 and 104.73±5.93, respectively.
These values were not significantly different from those of the control
group (112.02±4.94, 104.83±4.35; P>0.05; n=10)
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dopaminergic neurons cannot sufficiently explain the delay
of stomach emptying because dopaminergic neurons inhibit
gastrointestinal motility (Li et al. 2006). In other words, the
loss of gastrointestinal dopaminergic neurons should speed
up rather than slow down gastric emptying. Autopsy studies
of PD patients found that Lewy bodies mainly exist in the
soma and dendrites of vasoactive intestinal peptide-positive
neurons, but rarely in the soma and dendrites of TH-
positive neurons (Wakabayashi et al. 1990). We found that
damaging the substantia nigra with 6-OHDA can increase
dopaminergic neurons in gastric antrum and proximal colon
myenteric plexus, which was consistent with the results of
Western blot.
Constipation is the most common gastrointestinal symp-
tom of Parkinson’s disease patients. Recent studies have
shown that 20% of PD patients experienced constipation
symptom (Siddiqui et al. 2002). Jost and Schimrigk found
that 80% of surveyed PD patients had extended colonic
transit time (Jost and Schimrigk 1991). Studies from
Greene et al. (2009) have showed that rotenone-induced
PD rats had transiently reduced stool frequency. It was
found that fecal excretion and stool water content were
significantly lower in the 6-OHDA group than in the
control group at 4 weeks after PD induction. Giant
migrating contractions (GMCs) is the major colon motility
type that is related to human and rat fecal excretion
(Malcolm and Camilleri 2000). Constitutive DA release
can inhibit rat colon GMCs (Gonzalez and Sarna 2001).
Enteric dopaminergic neuronal loss can induce active colon
motility in MPTP-treated mice, which leads to a higher
fecal excretion frequency (Anderson et al. 2007). This
finding is consistent with the results of a dopamine D2
receptor knockout study (Li et al. 2006). Our study showed
that TH-positive neurons increase in both the gastric antrum
and the colon of 6-OHDA lesioned rats, which was
consistent with the results of Western blot. Therefore,
gastrointestinal DA content also increases and likely led to
constipation.
Enteric dopaminergic neurons represent only a small
portion of enteric neurons, and enteric non-dopaminergic
neurons could also be damaged during the progression of
PD. Anderson et al. generated a PD mouse model through
intraperitoneal injection of the neurotoxin MPTP and found
that the number of nitric oxidergic neurons did not change
(Anderson et al. 2007). Blandini et al. (2008) generated a
PD rat model through directional stereotaxic brain injection
of neurotoxin 6-OHDA and found slow colon motility as
well as nitric oxidergic neuronal loss in the myenteric
plexus. Another study reported that a primate PD model
generated with MPTP had more nitric oxidergic neurons
(Chaumette et al. 2009). Our studies showed that the
number of nNOS-positive neurons decreased significantly
Fig. 5 The protein expression of TH, nNOS, and ChAT in the gastric
antrum and colon tissue of the control and 6-OHDA-treated rats.
Western blot showing TH, nNOS, and ChAT in the gastric antrum and
colon in control and 6-OHDA-treated rats (a). β-Actin was analyzed
as a loading control. Cst Gastric antrum of the control group; Pst
gastric antrum of the 6-OHDA group; Cco colon tissue of the control
group; Pco colon tissue of the 6-OHDA group. The bar graph showed
the quantitative analysis of TH, nNOS, and ChAT in the gastric
antrum (b)a n dc o l o n( c). Protein expression of TH increased
significantly in the gastric antrum and colon in 6-OHDA-treated rats
(P<0.01); additionally, nNOS decreased significantly (P<0.01), and
there were no significant changes in ChAT (P>0.05; n=10)
22 J Mol Neurosci (2012) 47:15–25in both the gastric antrum and the proximal colon myenteric
plexus in the 6-OHDA group, which was consistent with
the results of Western blot. The nNOS mRNA level was
also significantly lower in the 6-OHDA group. As an
important inhibitory neurotransmitter in intestinal peptide
nerves, the major role of NO is to relax gastrointestinal
smooth muscle. Deficiencies in NO can result in sustained
spastic bowel stenosis and impaired gastric antrum relaxa-
tion, which leads to slow colonic transit and a delay of
gastric emptying. Therefore, both the constipation and the
delay gastric emptying in PD patients could be due to
impaired descending inhibition mediated by nitric oxide
during the peristalsis. Impairment of enteric nitric oxidergic
neurons could induce over contraction of smooth muscle,
Fig. 6 Changes in the levels of TH, nNOS, and ChAT mRNAs in the
gastric antrum and colon tissue. a–c TH, nNOS, and ChAT in the
gastric antrum and colon tissue, respectively. β-Actin was used as an
internal control. M Marker; Cst gastric antrum of the control group;
Pst gastric antrum of the 6-OHDA group; Cco colon tissue of the
control group; Pco colon tissue of the 6-OHDA group. The bar graph
showed the quantitative analysis of TH, nNOS, and ChAT in the
gastric antrum (d) and colon (e). Total RNA was isolated from tissue
using the conventional Trizol method. First strand cDNA was
synthesized with a reverse transcription kit. Changes in TH, ChAT,
and nNOS mRNA levels in the gastric antrum and colon tissue were
determined via RT-PCR. The TH product size was 1,184 bp, the β-
actin2 product size was 595 bp, the nNOS product size was 386 bp,
the β-actin1 product size was 207 bp, and the ChAT product size was
315 bp. TH mRNA levels of the gastric antrum and in the proximal
colon tissue in 6-OHDA group were 0.662±0.011and 0.585±0.012.
These values were significantly lower than those of the control group
(1.232±0.027, 1.172±0.026), and the difference between the two
groups was statistically significant (P<0.01). nNOS mRNA levels of
the gastric antrum and in the proximal colon tissue in 6-OHDA group
were 0.746±0.012 and 0.716±0.015. These values were significantly
lower than those of the control group (1.563±0.031, 1.489±0.030),
and the difference between the two groups was statistically significant
(P<0.01). ChAT mRNA levels of the gastric antrum and in the proximal
colon tissue in 6-OHDA group were 1.157±0.037 and 1.154±0.031.
These values were not significantly different from those of the control
group (1.134±0.067, 1.138±0.069; P>0.05; n=10)
Table 2 mRNA expression levels of TH, nNOS, and ChAT in gastric antrum and colon tissue from the 6-OHDA and control groups (x±s,n=10)
Group Gastric antrum Colon
TH nNOS ChAT TH nNOS ChAT
Control 1.232±0.027 1.563±0.031 1.134±0.067 1.172±0.026 1.489±0.030 1.138±0.069
6-OHDA 0.662±0.011* 0.746±0.012* 1.157±0.037 0.585±0.012* 0.716±0.015
* 1.154±0.031
*P<0.01 compared to the control group
J Mol Neurosci (2012) 47:15–25 23leading to muscle spasm and slow colon motility increase
water absorption from intestinal content. Therefore, the
stool water content of the 6-OHDA group rats was
significantly less than that of the control group.
Anderson et al. 2007 generated a PD model through
intraperitoneal injection of the neurotoxin MPTP, and they
found no changes in the number of cholinergic neurons.
Greene et al. (2009) induced a PD rat model through
chronic systemic administration of mitochondrial complex
1 inhibitor rotenone. The model led to a delay in gastric
emptying as well as a transient decrease in defecation
frequency, but the number of intestinal cholinergic neurons
did not change. A study by Chaumette et al. (2009) found
that the acetylcholine content in the myenteric plexus of
MPTP- treated monkeys did not change. The immuno-
histochemical results in our study showed no significant
differences between the two groups with respect to
gastrointestinal ChAT immunopositivity or ChAT mRNA
levels, which were consistent with the results of Western
blot. The tyrosine hydroxylase mRNA levels in the
antrum and proximal colon of the 6-OHDA group were
significantly lower than those of the control group,
which may be the result of negative feedback regulation.
Because TH immunoreactivity increased in the antrum
and proximal colon of the 6-OHDA lesion’sr a t s ,t h e
enhanced DA may act on the D1 and D2 receptors.
Stimulation of D2 receptor plays an important role in the
negative feedback regulation of dopamine production
(via TH) (Li et al. 2006). Therefore, an increasein
gastrointestinal DA level may cause a decrease in tyrosine
hydroxylase mRNA levels, which would explain the
decrease in antral and proximal colonic TH mRNA levels
in the 6-OHDA lesion’sr a t s .
Mounting evidence has demonstrated that gastrointestinal
symptoms in Parkinson’s disease are associated with the
changes in neurotransmitters in the ENS. However, important
questionraisedfromthepresentstudyishowmightthelossof
nigrostriatal dopaminergic neurons influence neurotransmit-
tersintheENS.Furtherinvestigationsareneededtoclarifythe
complex relationship among these phenomena and to better
understand the gastrointestinal symptoms of PD.
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